Trevi to launch Phase 2 trials to test Haduvio for IPF-related cough | Coughing frequency reduced in most patients on oral Haduvio, data show | Pulmonary Fib...
Trevi Therapeutics plans to launch two Phase 2 clinical trials testing Haduvio for chronic cough in people with idiopathic pulmonary fibrosis.| Pulmonary Fibrosis News
